FOXM1 and breast cancer: FDI-6 has been identified as a FOXM1-specific inhibitor in breast cancer cells by blocking the DNA binding activity of FOXM1, and its effect is selective for FOXM1 target genes without affecting genes regulated by homologous forkhead family factors [33].